Cost effectiveness of risk reduction: the managed care perspective

Shalowitz, Mervin; Heaton, Alan

doi:10.1016/s0002-9343(96)00323-3

Cited by 7 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It should be recognized that underutilization of effective preventive therapies also contributes to higher overall medical costs. Even though utilization of drugs incurs expense, effective medications can produce substantial savings by reducing the need for additional medical care [39].…”

Section: Cost-benefit Implications Of Utilization and Compliancementioning

confidence: 99%

Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics

Rockson

2000

Curr Atheroscler Rep

View full text Add to dashboard Cite

Coronary heart disease remains the leading cause of death in the United States. Although coronary heart disease and stroke entail very expensive therapies and extensive hospital utilization, the cost of preventive measures is also quite expensive. In this review, the factors that determine the cost-effectiveness of statin therapy for the primary and secondary prevention of coronary heart disease are discussed. A risk-based strategy for the selection of patients seems to provide cost-effective utilization of this potent treatment strategy. Appropriate patient selection should be accompanied by aggressive measures to improve utilization and compliance through improved physician and patient education.

show abstract

Section: Cost-benefit Implications Of Utilization and Compliancementioning

confidence: 99%

Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics

Rockson

2000

Curr Atheroscler Rep

View full text Add to dashboard Cite

show abstract

Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms

McCullough

Ayad

O’Neill

et al. 1998

Clinical Cardiology

View full text Add to dashboard Cite

SummaryBackground: Although inroads have been made in the outpatient evaluation of chest pain, the majority of hospitals in the United States do not have chest pain centers and the direct costs associated with hospital admissions in lqw-risk patients is unknown.Hypothesis: The study was undertaken to evaluate the cost and outcomes of admission to the hospital for patients with acute chest pain and essentially normal electrocardiograms (ECGs).Methods: For that purpose, we reviewed 1,670 patients presenting to our emergency department with chest pain over a 5-month period in 1994. Of these, 567 [34.0%, confidence interval (CI) 95%, 3 I .7-36.3%] patients were considered to be low risk by ECG criteria alone.Results: Complete clinical and financial data were avail-

show abstract

Medicaid, managed care, and the care of patients hospitalized for acute myocardial infarction

Sloan¹,

Rankin

Whellan

et al. 2000

American Heart Journal

View full text Add to dashboard Cite

Cost effectiveness of risk reduction: the managed care perspective

Cited by 7 publications

References 8 publications

Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics

Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics

Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms

Medicaid, managed care, and the care of patients hospitalized for acute myocardial infarction

Contact Info

Product

Resources

About